I'm tired of traders always blaming the company when the PPS doesn't go in the direction they want. If they are diluting, prove it. Call the TA and get the latest O/S. And if they are diluting its because they need funds to execute their business plan. I don't know what else this company can do to prove their worthiness. Investors just have to realize the slower pace that things move when it comes to the FDA and clinical trials. I'm a believer in this company until I see a reason not to. If they get IND rejected or fail with clinical trials then I'll worry. Until then, I want to congratulate Regen for having accomplished so much in its short time as a company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.